Who
Carol A. Vallone
Director
Company insider
Files Form 4 as: Director, Definium Therapeutics; Director, Beverly National.
In numbers
- Trades disclosed
- 26
- Buys
- 1
- Sells
- 0
- Bought
- $1,020
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 7 Jan 2008
- Last trade
- 18 Sep 2026
- Last filed
- 18 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Sep 2026filed 18 Sep 2026 | DFTX Definium TherapeuticsBiotechnology | SEC FORM 4 Code M | $39K1,086 at $35.52 | filing |
| 18 Sep 2026filed 18 Sep 2026 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,086 at $0.00 | filing |
| 18 Sep 2026filed 18 Sep 2026 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,086 at $0.00 | filing |
| 18 Sep 2026filed 18 Sep 2026 | DFTX Definium TherapeuticsBiotechnology | SEC FORM 4 Code M | $39K1,086 at $35.52 | filing |
| 11 Jun 2026filed 15 Jun 2026 | DFTX Definium TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,666 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,188 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,188 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | DFTX Definium TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,666 at $0.00 | filing |
| 12 Jun 2025filed 16 Jun 2025 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —75,187 at $0.00 | filing |
| 10 Jun 2024filed 12 Jun 2024 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —16,506 at $0.00 | filing |
| 21 Jun 2023filed 23 Jun 2023 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,203 at $0.00 | filing |
| 21 Jun 2023filed 23 Jun 2023 | DFTX Definium TherapeuticsBiotechnology | SEC FORM 4 Code A | —13,671 at $0.00 | filing |
| 1 Jun 2022filed 6 Jun 2022 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —133,744 at $0.00 | filing |
| 1 Jun 2022filed 6 Jun 2022 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —98,198 | filing |
| 1 Jun 2022filed 6 Jun 2022 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —774,673 | filing |
| 1 Jun 2022filed 6 Jun 2022 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,353 | filing |
| 1 Jun 2022filed 6 Jun 2022 | DFTX Definium TherapeuticsBiotechnology | SEC FORM 4 Code A | —43,104 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —133,744 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —98,198 | filing |
| 1 Jun 2022filed 3 Jun 2022 | DFTX Definium Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —774,673 | filing |
News
No headline names them, or the companies they trade most, lately.